News & Updates

Show Multimedia Only

Cardiovascular drugs do not worsen COVID-19 outcomes

11 Jan 2022 by

Use of cardiovascular medications does not lead to poor COVID-19 clinical outcomes among high-risk patients, such as those with hypertension, according to a study.

11 Jan 2022

Old age, non-English language tied to incomplete telehealth visit

11 Jan 2022

Older patients, non‒English-speaking individuals, and ethnic/racial minorities are less likely to complete a video telemedicine encounter for ophthalmic care during the COVID-19 pandemic, a study has found.

11 Jan 2022

Intensive rehab benefits lung cancer patients undergoing surgery

11 Jan 2022 by

A rehabilitation programme comprising intensive perioperative pulmonary rehabilitation (PR) and standard of care (SC) led to improved exercise capacity and tolerance in individuals with early-stage non-small-cell lung cancer (NSCLC) who are undergoing lung resection, the PUREAIR trial suggests.

11 Jan 2022

Choline supplementation during pregnancy improves infant attention span

11 Jan 2022 by

Mothers who consume twice the recommended amount of choline during their third trimester of pregnancy give birth to children with significantly better sustained attention at age 7 years, according to a recent trial.

11 Jan 2022

PDEV inhibition falls short of improving renal response in patients with preheart failure

11 Jan 2022

The use of a phosphodiesterase type 5 (PDEV) inhibitor in patients with preheart failure (pre-HF) does not appear to produce improvements in glomerular filtration rate and urinary sodium/cGMP excretion as compared with placebo, as shown in a study.

11 Jan 2022

Newborn screening detects late-onset Pompe disease, allows for early intervention

11 Jan 2022

Newborn screening (NBS) can facilitate the early detection of late-onset Pompe disease, leading to timely intervention, a recent study has found.

11 Jan 2022

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease

11 Jan 2022

Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

11 Jan 2022

IVO-AZA combo therapy boosts OS in IDH1-mutated AML

11 Jan 2022 by

The combination of ivosidenib and azacitidine (IVO-AZA) improves event-free and overall survival (OS) vs AZA alone in patients with acute myeloid leukaemia (AML) bearing somatic mutations in isocitrate dehydrogenase 1 (IDH1), the AGILE trial has shown.

11 Jan 2022

Pyrotinib + capecitabine extends OS in metastatic breast cancer

10 Jan 2022 by

Patients with previously treated HER2-positive metastatic breast cancer (mBC) experienced a 31 percent reduced risk of death when treated with pyrotinib plus capecitabine than lapatinib plus capecitabine, according to updated results of the phase III PHOEBE trial from China.

10 Jan 2022

Hormonal contraceptive use ups risk of glaucoma in women

10 Jan 2022

Women of reproductive age who regularly use hormonal contraceptives (HCs) are at increased risk of glaucoma, suggests a recent study.

10 Jan 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Cardiovascular drugs do not worsen COVID-19 outcomes

Old age, non-English language tied to incomplete telehealth visit

Intensive rehab benefits lung cancer patients undergoing surgery

Choline supplementation during pregnancy improves infant attention span

PDEV inhibition falls short of improving renal response in patients with preheart failure

Newborn screening detects late-onset Pompe disease, allows for early intervention

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease

IVO-AZA combo therapy boosts OS in IDH1-mutated AML

Pyrotinib + capecitabine extends OS in metastatic breast cancer

Hormonal contraceptive use ups risk of glaucoma in women